MY134493A - Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method - Google Patents

Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method

Info

Publication number
MY134493A
MY134493A MYPI94003581A MYPI9403581A MY134493A MY 134493 A MY134493 A MY 134493A MY PI94003581 A MYPI94003581 A MY PI94003581A MY PI9403581 A MYPI9403581 A MY PI9403581A MY 134493 A MY134493 A MY 134493A
Authority
MY
Malaysia
Prior art keywords
thrombopoietin
peptides
fragments
same
nucleic acids
Prior art date
Application number
MYPI94003581A
Inventor
Dan L Eaton
Frederic J De Sauvage
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/196,689 external-priority patent/US8357513B1/en
Priority claimed from US08/249,376 external-priority patent/US8192955B1/en
Priority claimed from US08/348,657 external-priority patent/US6660256B1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MY134493A publication Critical patent/MY134493A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

ISOLATED THROMBOPOIETIN ( TPO ), AND RECOMBINANT OR SYNTHETIC METHODS OF PREPARING AND PURIFYING TPO ARE DISCLOSED. VARIOUS FORM OF TPO ARE SHOWN TO INFLUENCE THE REPLICATION,DIFFERENTATION OR MATURATIONOF BLOOD CELLS, ESPECIALLY MEGAKARYOCYTES AND MEGAKARYOCYTE PROGENITOR CELLS. ACCORDINGLY, THESE COMPOUNDS MAY BE USED FOR TREAMENT OF THROMBOCYTOPENIA.
MYPI94003581A 1994-01-03 1994-12-30 Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method MY134493A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US17655394A 1994-01-03 1994-01-03
US18560794A 1994-01-21 1994-01-21
US08/196,689 US8357513B1 (en) 1994-01-03 1994-02-15 Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US22326394A 1994-04-04 1994-04-04
US08/249,376 US8192955B1 (en) 1994-01-03 1994-05-25 Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
US34865894A 1994-12-02 1994-12-02
US08/348,657 US6660256B1 (en) 1994-01-03 1994-12-02 Porcine mpl ligand

Publications (1)

Publication Number Publication Date
MY134493A true MY134493A (en) 2007-12-31

Family

ID=47291673

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI94003581A MY134493A (en) 1994-01-03 1994-12-30 Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method

Country Status (3)

Country Link
KR (1) KR20040065249A (en)
MY (1) MY134493A (en)
UY (1) UY23886A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101719355B1 (en) * 2016-11-14 2017-03-27 (주)케어젠 Peptides Having Activities of Skin Condition Improvement and Uses Thereof
CN118050528B (en) * 2024-04-16 2024-07-16 山东泉港药业有限公司 Method for detecting thrombopoietin peptoid biological activity

Also Published As

Publication number Publication date
UY23886A1 (en) 1995-06-30
KR20040065249A (en) 2004-07-21

Similar Documents

Publication Publication Date Title
BG100693A (en) Thrombopoietin
EP0723555A4 (en) Chimeric proteins which block complement activation
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
EP0477971A3 (en) Human cnp gene and precursor protein
MD430C2 (en) Method for human leucocytar interferone preparation
ATA401180A (en) Recombinant DNA molecule coding for the tree pollen allergen P14, polypeptides prepared and derived therefrom, and the use thereof
IL87647A0 (en) Dna sequences,recombinant dna molecules and processes for producing soluble t4 proteins
DE3583564D1 (en) DNA SEQUENCES OF THE EBV GENOME, RECOMBINANT DNA MOLECULES, METHOD FOR THE PRODUCTION OF EBV-RELATED ANTIGENS, DIAGNOSTIC COMPOSITIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ANTIGENS.
EP0218531A3 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
DE68926679D1 (en) PHYSIOLOGICALLY ACTIVE POLYPEPTIDE, RECOMBINANT PLASMIDE, RECOMBINANT MICROBIAL CELLS, MEDICAL PREPARATION AND METHOD FOR OBTAINING THE PURIFIED POLYPEPTIDE
ES8609475A1 (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same.
HUT58107A (en) Process for producing heparing-binding proteins, dna encoding them and pharmaceutical compositions comprising the proteins
EP0054330A3 (en) Dna sequences encoding the various allelic forms of mature thaumatin, and cloning vehicles comprising said dna's and their use in transforming microorganisms
MX9203138A (en) DOMAIN OF LINK CD2-ANTIGEN 3 (LFA-3) ASSOCIATED WITH FUNCTION LYMPHOSITES.
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
FI863626A7 (en) DNA sequences, recombinant DNA molecules and methods for producing human lipocortin-like polypeptides.
EP0546087A4 (en)
FI896261A7 (en) Method for producing a protein or polypeptide, DNA sequence encoding the polypeptide, microorganism containing the DNA sequence and polypeptide and its use as a pharmaceutical preparation
MX9702341A (en) Cytokine designated lerk-6.
AU2820992A (en) Polypeptide, dna fragment encoding the same, drug composition containing the same and process for producing the same
HUT44609A (en) Process for preparing new polypeptides
EP0317279A3 (en) Peptides for use in the purification of factor viii
IL127363A0 (en) IL-1/TNF-alpha-activated kinase and methods of making and using the same
WO1990003394A3 (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
EP0723016A3 (en) Activating factor of leukocytes